Literature DB >> 25653288

Unlocking the mysteries of TDP-43.

Keith A Josephs1, Peter T Nelson2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25653288     DOI: 10.1212/WNL.0000000000001322

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  10 in total

1.  Neuroimaging markers associated with maintenance of optimal memory performance in late-life.

Authors:  Maria Dekhtyar; Kathryn V Papp; Rachel Buckley; Heidi I L Jacobs; Aaron P Schultz; Keith A Johnson; Reisa A Sperling; Dorene M Rentz
Journal:  Neuropsychologia       Date:  2017-05-01       Impact factor: 3.139

2.  Diagnostic and prognostic value of human prion detection in cerebrospinal fluid.

Authors:  Aaron Foutz; Brian S Appleby; Clive Hamlin; Xiaoqin Liu; Sheng Yang; Yvonne Cohen; Wei Chen; Janis Blevins; Cameron Fausett; Han Wang; Pierluigi Gambetti; Shulin Zhang; Andrew Hughson; Curtis Tatsuoka; Lawrence B Schonberger; Mark L Cohen; Byron Caughey; Jiri G Safar
Journal:  Ann Neurol       Date:  2017-01       Impact factor: 10.422

3.  Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; Amanda M Serie; Ralph B Perkerson; Billie J Matchett; Clifford R Jack; David S Knopman; Ronald C Petersen; Joseph E Parisi; Leonard Petrucelli; Matthew Baker; Rosa Rademakers; Jennifer L Whitwell; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2019-01-02       Impact factor: 17.088

4.  TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.

Authors:  Bryan D James; Robert S Wilson; Patricia A Boyle; John Q Trojanowski; David A Bennett; Julie A Schneider
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

5.  TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.

Authors:  Margaret E Flanagan; Brenna Cholerton; Caitlin S Latimer; Laura S Hemmy; Steven D Edland; Kathleen S Montine; Lon R White; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.

Authors:  Keith A Josephs; Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Amanda M Liesinger; Leonard Petrucelli; Matthew L Senjem; Robert J Ivnik; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson
Journal:  Ann Neurol       Date:  2015-09-16       Impact factor: 10.422

7.  Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease.

Authors:  Mark Cohen; Brian Appleby; Jiri G Safar
Journal:  Prion       Date:  2016       Impact factor: 3.931

8.  Ring trial of 2nd generation RT-QuIC diagnostic tests for sporadic CJD.

Authors:  Christina D Orrú; Bradley R Groveman; Aaron Foutz; Matilde Bongianni; Franco Cardone; Neil McKenzie; Audrey Culeux; Anna Poleggi; Katarina Grznarova; Daniela Perra; Michele Fiorini; Xiaoqin Liu; Anna Ladogana; Marco Sbriccoli; Andrew G Hughson; Stéphane Haïk; Alison J Green; Michael D Geschwind; Maurizio Pocchiari; Jiri G Safar; Gianluigi Zanusso; Byron Caughey
Journal:  Ann Clin Transl Neurol       Date:  2020-11       Impact factor: 4.511

Review 9.  Populations of Tau Conformers Drive Prion-like Strain Effects in Alzheimer's Disease and Related Dementias.

Authors:  Lenka Hromadkova; Mohammad Khursheed Siddiqi; He Liu; Jiri G Safar
Journal:  Cells       Date:  2022-09-26       Impact factor: 7.666

10.  Artificial strain of human prions created in vitro.

Authors:  Chae Kim; Xiangzhu Xiao; Shugui Chen; Tracy Haldiman; Vitautas Smirnovas; Diane Kofskey; Miriam Warren; Krystyna Surewicz; Nicholas R Maurer; Qingzhong Kong; Witold Surewicz; Jiri G Safar
Journal:  Nat Commun       Date:  2018-06-04       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.